Disclosed are a resin composition comprising 20 to 50 mass % of a polyphenylene ether-based resin (a), 0.1 to 9 mass % of a polyphenylene ether-based resin modified with an unsaturated carboxylic acid or acid anhydride thereof (b), 15 to 50 mass % of a homopolystyrene (c), 1 to 25 mass % of one or more selected from the group consisting of a hydrogenated block copolymer (d-1) and a rubber-modified polystyrene (d-2), and 5 to 35 mass % of glass fibers (e) which are surface-treated, a resin composition comprising 20 to 50 mass % of a polyphenylene ether-based resin (a), 15 to 50 mass % of a homopolystyrene (c), 5 to 35 mass % of glass fibers (e), and 0.01 to 1 mass % of compounds (f), a method of producing the same, a molded article, and a mechanical component and housing.

Provided is a curable composition having excellent workability and being capable of forming a cured product having super heat resistance by curing. The curable composition of the present disclosure includes a curable compound represented by Formula (1) below and a radical polymerization initiator. In the following formula, R.sup.1 and R.sup.2 each represent a curable functional group, and D.sup.1 and D.sup.2 each represent a single bond or a linking group. L represents a divalent group having a repeating unit containing a structure represented by Formula (I) below and a structure represented by Formula (II) below. Ar.sup.1 to A.sup.3 each represent an arylene group or a group in which two or more arylene groups are bonded via a single bond or a linking group. X represents —CO—, —S—, or —SO.sub.2—, and Y represents —S—, —SO.sub.2—, —O—, —CO—, —COO—, or —CONH—. n represents an integer of 0 or greater.

##STR00001##

A zwitterionic polysulfone formed from an allyl-containing monomer, a phenol-containing monomer, and an aryl-halide-containing monomer. The zwitterionic polysulfone may be incorporated into a desalination membrane.

The present disclosure provides a polyphenylene ether composition having a high glass transition temperature and a long-term solubility in a solvent, and exhibiting a low viscosity when being dissolved in a solvent. The polyphenylene ether composition of the present disclosure contains 60 mol % or more of a polyphenylene ether having the structure of Formula (1), wherein the ratio of the integrated value of the peak appearing at 7.6 to 8.3 ppm to the integrated value of the peak derived from the structure of the following Formula (2) in a .sup.1H-NMR measurement result is 1 or less, and the number average molecular weight in terms of polystyrene is 500 to 15,000 g/mol.

The present disclosure provides a polyphenylene ether composition having a high glass transition temperature and a long-term solubility in a solvent, and exhibiting a low viscosity when being dissolved in a solvent. The polyphenylene ether composition of the present disclosure contains 60 mol % or more of a polyphenylene ether having the structure of Formula (1), wherein the ratio of the integrated value of the peak appearing at 7.6 to 8.3 ppm to the integrated value of the peak derived from the structure of the following Formula (2) in a .sup.1H-NMR measurement result is 1 or less, and the number average molecular weight in terms of polystyrene is 500 to 15,000 g/mol.

An ion conducting polymer comprising a modified poly(phenylene oxide) is described. In an exemplary modified polymer, a portion of the monomeric units are attached to a sulfonate-substituted arylamino moiety, such as a monovalent derivative of phenoxy aniline trisulfonate (BOATS), to form a monomeric unit with a charged side chain. Ion conducting polymers can also be prepared with polyether-containing side chains. The ion conducting polymer can be used to prepare ion exchange membranes which can be used in a variety of applications, such as in non-aqueous redox flow batteries and related energy storage systems.

The present invention discloses a conjugate of PEG (polyethylene glycol) and rapamycin and use thereof, in particular use in preparation of a medicament for reducing immune response, wherein conjugate of PEG and rapamycin can remarkably lower the generation rate of an antibody directed to foreign immunogen, and reduce excessive immune responses caused by use thereof. The conjugate of PEG and rapamycin has beneficial effects of ensuring and even improving the treatment effect of a therapeutic agent, improving the own immunity of a subject, reducing and even eliminating graft rejection, and is advantageous in a relatively simple preparation process thereof, low cost, easy industrial production, and a high application value.

A rubber composition is based on at least one predominant vinylaromatic diene elastomer, having a vinylaromatic content of less than 10%; from 3 to 50 phr of a thermoplastic resin, denoted PPE resin, comprising optionally substituted polyphenylene ether units, the resin having a number-average molecular weight (Mn) of less than 6000 g/mol; from 5 to 60 phr of silica as predominant reinforcing filler; and a crosslinking system. Also disclosed are rubber articles comprising such a composition and in particular tires.

A zwitterionic polysulfone formed from an allyl-containing monomer, a phenol-containing monomer, and an aryl-halide-containing monomer. The zwitterionic polysulfone may be incorporated into a desalination membrane.

The invention pertains to a side-chain functionalized copolymer (P1) comprising reactive end-groups. The present invention also pertains to the preparation process of copolymer (P1) starting from copolymer (P0), as well as to the use of the copolymer (P1) in the preparation of a membrane, a composite material or a coating. The present invention also relates to a resin composition comprising at least the copolymer (P1) according to the present invention.